PMID- 24795053 OWN - NLM STAT- MEDLINE DCOM- 20141217 LR - 20140505 IS - 1550-8080 (Electronic) IS - 0091-7370 (Linking) VI - 44 IP - 2 DP - 2014 Spring TI - Tert-butylhydroquinone protects the spinal cord against inflammatory response produced by spinal cord injury. PG - 151-7 AB - Antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has been shown in our previous studies to play an important role in protection against spinal cord injury (SCI) induced inflammatory response. The objective of this study was to test whether tert-butylhydroquinone (tBHQ), a novel Nrf2 activator, can protect the spinal cord against SCI-induced inflammatory damage. Adult male Sprague-Dawley rats were subjected to laminectomy at T8-T9 and compression with a vascular clip. Three groups were analyzed: a sham group, a SCI group, and a SCI+rhEPO group (n=16 per group). We measured Nrf2 and nuclear factor kappa B (NF-kappaB) binding activities by an electrophoretic mobility shift assay (EMSA). We also measured the concentrations of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6) by an enzyme-linked immunosorbent assay (ELISA); we also measured hindlimb locomotion function by the Basso, Beattie, and Bresnahan (BBB) rating, spinal cord edema by wet/dry weight method, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) analysis. The results showed that the induction of the Nrf2 activity by tBHQ markedly decreased NF-kappaB activation and inflammatory cytokines production in the injured spinal cord. Administration of tBHQ also significantly attenuated SCI induced hindlimb locomotion deficits, spinal cord edema, and apoptosis. To conclude, pre-treatment with tBHQ could attenuate the spinal cord inflammatory response after SCI. FAU - Jin, Wei AU - Jin W AD - Department of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, 321 Zhongshan Road, Nanjing 210008, Jiangsu Province, China; phone: 86 25 83106666; njneirosurgery@163.com. FAU - Ni, Hongbin AU - Ni H FAU - Hou, Xiaoshan AU - Hou X FAU - Ming, Xing AU - Ming X FAU - Wang, Jing AU - Wang J FAU - Yuan, Baoyu AU - Yuan B FAU - Zhu, Tiansheng AU - Zhu T FAU - Jiang, Jian AU - Jiang J FAU - Wang, Handong AU - Wang H FAU - Liang, Weibang AU - Liang W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Ann Clin Lab Sci JT - Annals of clinical and laboratory science JID - 0410247 RN - 0 (Cytokines) RN - 0 (Hydroquinones) RN - 0 (Inflammation Mediators) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NF-kappa B) RN - 0 (Neuroprotective Agents) RN - 9007-49-2 (DNA) RN - C12674942B (2-tert-butylhydroquinone) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Blood-Brain Barrier/drug effects/pathology MH - Cytokines/metabolism MH - DNA/metabolism MH - Disease Models, Animal MH - Edema/complications/drug therapy/pathology/physiopathology MH - Hindlimb/drug effects/physiopathology MH - Hydroquinones/pharmacology/*therapeutic use MH - Immunohistochemistry MH - In Situ Nick-End Labeling MH - Inflammation/*complications/*drug therapy/pathology MH - Inflammation Mediators/metabolism MH - Male MH - Motor Activity/drug effects MH - NF-E2-Related Factor 2/metabolism MH - NF-kappa B/metabolism MH - Neuroprotective Agents/pharmacology/*therapeutic use MH - Protein Binding/drug effects MH - Rats, Sprague-Dawley MH - Spinal Cord/drug effects/*pathology/physiopathology/surgery MH - Spinal Cord Injuries/*complications/*drug therapy/physiopathology OTO - NOTNLM OT - Nrf2 OT - inflammatory response OT - spinal cord injury OT - tBHQ EDAT- 2014/05/06 06:00 MHDA- 2014/12/18 06:00 CRDT- 2014/05/06 06:00 PHST- 2014/05/06 06:00 [entrez] PHST- 2014/05/06 06:00 [pubmed] PHST- 2014/12/18 06:00 [medline] AID - 44/2/151 [pii] PST - ppublish SO - Ann Clin Lab Sci. 2014 Spring;44(2):151-7.